Crohn's disease: open trials in Hong Kong

4 open trials have a site in Hong Kong. Registry data; only the trial team decides who can take part.

NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Queen Mary Hospital (Site 3300), Hksar
Registry updated 2026-11-02
NCT07630883
A Pilot Study: Micro and NanoPlastics in Association With Crohn's Disease
Research · Mak Wing Yan
Prince of Wales Hospital, Hong Kong
Registry updated 2026-06-05
NCT04014413
Safety and Efficacy of Fecal Microbiota Transplantation
Trial Treatment · Chinese University of Hong Kong
The Chinese University of Hong Kong, Hong Kong
Registry updated 2024-08-22
NCT01140789
GWA Study in Patients With Inflammatory Bowel Disease
Research · Chinese University of Hong Kong
Prince of Wales Hospital, Hong Kong
Registry updated 2023-02-08

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)